跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
斯康杜尼 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Mepivacaine Hydrochloride Injection
Approved
化学药品
Mepivacaine Hydrochloride Injection
Novocol Pharmaceutical Of Canada, Inc
🇨🇳 National Medical Products Administration
Approval Date
Mar 15, 2023
Approval ID
1xpZqtYvJMg
Company
Novocol Pharmaceutical Of Canada, Inc
Type
化学药品
Approval Details
Approval Id
1xpZqtYvJMg
Approval Number
国药准字HJ20181204
Generic Name
盐酸甲哌卡因注射液
Generic Name En
Mepivacaine Hydrochloride Injection
Trade Name
斯康杜尼
Drug Type
化学药品
Dosage Form
注射剂
Strength
1.8ml:54mg
Reg Date
2023-03-15
Expired Date
2028-03-14
Company Name
Novocol Pharmaceutical Of Canada, Inc
Production Company Name
Novocol Pharmaceutical Of Canada, Inc
Company Detail Path
/organization/novocol-pharmaceutical-of-canada-inc
Production Company Detail Path
/organization/novocol-pharmaceutical-of-canada-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 15, 2023
Approval ID
1xpZqtYvJMg
Type
化学药品
Back to NMPA Approvals